Evidence mapPaperPMID 21870049Full record

Trial reportObesity surgery2012

Prospective, multicenter, 3-year trial of laparoscopic adjustable gastric banding with the MIDBAND™.

Christian Gouillat, Angélique Denis, Perrine Badol-Van Straaten, Vincent Frering, Jacques Tussiot, Pierre Campan, Gérard Aulagnier, Valeria Costamagna, Jean-François Ain, Robert Portet and 9 more

Abstract readClinical TrialMulticenter Study
PubMed Publisher
In one paragraph

Trial report in Obesity surgery, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
2.7field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 14 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 5 institutions in 2 countries.

Christian GouillatCentre de chirurgie de l'obésité, Hospices Civils de Lyon, Université de Lyon, 69 317, Lyon, France. christian.gouillat@chu-lyon.fr
Angélique Denis
Perrine Badol-Van Straaten
Vincent Frering
Jacques Tussiot
Pierre Campan
Gérard Aulagnier
Valeria Costamagna
Jean-François Ain
Robert Portet
Michel Roche
Celestin Esso
Jean-Marie Molasoko
Yves Claret
Jacques Desplantez
Sébastien Le Page
Marie Cécile Blanchet
Maud Robert
Isabelle Jaisson-Hot
Hospices Civils de Lyon · FRUniversité Claude Bernard Lyon 1 · FRClinique Mutualiste Chirurgicale · FRHôpital de la Conception · FRLyon College · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAlthough laparoscopic adjustable gastric banding (LAGB) is a popular metabolic/bariatric procedure, few prospective studies have assessed its outcomes. This study aimed to prospectively assess LAGB safety and effectiveness outcomes using the MIDBAND™ (MID, Dardilly, France).

methodsBetween May 2005 and September 2006, 262 morbidly obese patients underwent primary gastric banding with pars flaccida technique in 13 French medical centers. Excess weight loss and change in body mass index (BMI, kilogram per square meter), percentage of patients with comorbidities, and obesity-related complications were recorded. Patients were followed at 6-month intervals for 3 years. A multivariable individual growth model was used to analyze weight change over time and determine potential predictors of weight loss.

resultsThe majority of patients were female (n = 233, 89%), with mean age of 36.4 ± 9.7 years. At 3 years, LAGB with MIDBAND resulted in significant decrease in mean BMI from 41.8 ± 4.2 to 30.7 ± 5.8 (p < 0.0001). Median excess weight loss and excess BMI loss were 61% and 68%, respectively. The prevalence of obesity-related comorbidities had significantly decreased from 71% to 15% (p < 0.0001). Complications were observed in 26 patients (10%); device-related complications occurred in 20 patients (8.2%), requiring band removal in 8 (3.3%), and port revision in 8 (3.3%). Individual growth analysis identified significant predictors of weight loss including the number of follow-up visits.

conclusionProspective outcomes demonstrate the safety and efficacy of gastric banding over time using the MIDBAND. Individual growth modeling demonstrated that postoperative weight loss is strongly related to the frequency and consistency of follow-up visits.

Indexed as

LaparoscopyAdolescentAdultBody Mass IndexComorbidityDevice RemovalDiabetes MellitusFemaleFollow-Up StudiesFranceGastroplastyHumansHypertensionJoint DiseasesMaleMiddle Aged

Identifiers

PMID21870049
OpenAlexW2088555792

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.